Barawaclawik (Talk | contribs) |
|||
Line 3: | Line 3: | ||
<h3>Ciprofloxacin resistance cassette in pSB1C3 (<a href="http://parts.igem.org/Part:BBa_K1930004">BBa_K1930004</a>)</h3> | <h3>Ciprofloxacin resistance cassette in pSB1C3 (<a href="http://parts.igem.org/Part:BBa_K1930004">BBa_K1930004</a>)</h3> | ||
− | <p>To design a qnrS1 resistance cassette BioBrick we designed a gBlock that contains the <em>Bacillus subtilis</em> constitutive promoter P<sub>AtpI</sub>, which is active from a very early stage of germination and includes a ribosome binding site. The gBlock also contains the original <em>qnrS1</em> gene sequence from <em>E. coli</em>, the double terminator (<a href="http://parts.igem.org/Part:BBa_B0015">BBa_B0015</a>) from iGEM as well as the prefix and suffix for BioBricks. In summary the ciprofloxacin cassette consists of the following parts P<sub>AtpI</sub>+RBS+<em>qnrS1</em>+2TER, see plasmid map below.</p> | + | <p>To design a <em>qnrS1</em> resistance cassette BioBrick we designed a gBlock that contains the <em>Bacillus subtilis</em> constitutive promoter P<sub>AtpI</sub>, which is active from a very early stage of germination and includes a ribosome binding site. The gBlock also contains the original <em>qnrS1</em> gene sequence from <em>E. coli</em>, the double terminator (<a href="http://parts.igem.org/Part:BBa_B0015">BBa_B0015</a>) from iGEM as well as the prefix and suffix for BioBricks. In summary the ciprofloxacin cassette consists of the following parts P<sub>AtpI</sub>+RBS+<em>qnrS1</em>+2TER, see plasmid map below.</p> |
<figure> | <figure> |
Revision as of 20:55, 19 October 2016
To design a qnrS1 resistance cassette BioBrick we designed a gBlock that contains the Bacillus subtilis constitutive promoter PAtpI, which is active from a very early stage of germination and includes a ribosome binding site. The gBlock also contains the original qnrS1 gene sequence from E. coli, the double terminator (BBa_B0015) from iGEM as well as the prefix and suffix for BioBricks. In summary the ciprofloxacin cassette consists of the following parts PAtpI+RBS+qnrS1+2TER, see plasmid map below. The sequence of the qnrS1 gene was amplified from the gBlock qnrS1
E. coli ordered from IDT. Primers used for the
amplification were F-qnrs1 e.coli and R-qnrs1 e.coli (primer sequences can be found here).
50 µl PCR assay was performed according to the following
protocol. For detailed information on how to prepare and run agarose gels see
following protocol. The PCR of the qnrS1 sequence from the IDT gBlock was successful. It
was verified by DNA electrophoresis. A band with the correct
size of 1194 bp could be seen. PCR product was subsequently cleaned with (PCR Purification Kit – Jena Bioscience). 28/09/16 The qnrS1 gene should have been cloned into the pSB1C3. For this case the vector BBa_J04450 was used. The qnrS1 gene and BBa_J04450 were cut with the restriction enzymes EcoRI and PstI. 20 μl RD assay was performed according to the following protocol. For detailed information on how to prepare and run
agarose gels see following protocol. Bands of the sizes 2029 bp for the vector and 1176 bp for the gene
were expected. The digestion was successful because bands for both expected
fragments could be seen on the gel, namely RFP insert is 1069 bp and the
pSB1C3 backbone is 2019 bp. The digested samples were cut out from the gel and the DNA was
extracted using the Agarose gel Extraction Kit (Jena Bioscience). 28/09/16: After restriction digestion ligation was performed. 6 µl
qnrS1 insert DNA were ligated to 4 µl pBS1C3 vector DNA. The
ligation took place for 2 h at room temperature. 20 µl ligation assay was performed according to the following protocol. 28/09/16 After ligation the ciprofloxacin resistance cassette in pSB1C3 was transformed into E. coli Top10 cells. The transformation was plated on plates containing 50 µg/ml
chloramphenicol. The transformation was performed according to the
transformation protocol. 29/09/16: To analyze the success of the transformation 12 samples
were picked and a colony PCR was performed according to the following protocol. The primers F-qnrs1 e.coli and R-qnrs1
e.coli were used. Primer sequences can be found here.
For detailed information on how to prepare and run agarose gel see following protocol. The colony PCR did not bring clear results. 30/09/16: To further analyze the success of the transformation
four colonies were grown as overnight cultures (started on 29/09/16)
in LB and 50 µg/ml chloramphenicol. On the next day plasmid isolation was performed and plasmids were digested using the enzymes EcoRI and PstI according to the following restriction digestionprotocol. For detailed information on how to prepare and run agarose gel see following protocol. Two out of the four digested samples showed bands of the expected
sizes 2029 bps for the vector and 1184 for the gene could be seen. The two samples that showed the correct digestion pattern in the restriction digestion control were sent for sequencing with the primers VF2 and VR, see primer list. These two samples showed the correct sequence (Figure 5.1-5.4, 5.1 mutant 1 forward, 5.2: mutant 2 forward, 5.3: mutant 1 reverse, 5.4: mutant 2 reverse ). For further experiment see the construction of the plasmid ciprofloxacin resistance cassette in BBa_K823023.Ciprofloxacin resistance cassette in pSB1C3 (BBa_K1930004)
PCR
Experiment:
PCR mixture:
PCR set-up:
95ºC 2:00 min 95ºC 30s (12X) 60ºC 30s (12X) 72ºC 1:30 min (12X) 72ºC 2:00 min 10ºC on hold DNA Electrophoresis:
Conclusion:
Procedure after gel validation:
Restriction digestion
Experiment:
RD mixture:
DNA Electrophoresis:
Conclusion:
Procedure after gel validation:
Ligation
Experiment:
Ligation mixture:
Transformation
Experiment:
DNA electrophoresis:
Conclusion:
Experiment:
DNA electrophoresis:
Conclusion:
Validation
Experiment:
Experiments